Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Kah Whye Peng

Mayo Clinic Rochester, Department: Na

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Imanis Life Sciences LLC

Disclosed Value

Value cannot be readily determined

Listed Reason

Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)

Please see attached

Listed Research Project

Mayo SPORE in Brain Cancer

Compared to other more common cancers malignant gliomas are responsible for a disproportionate amount of morbidity and mortality because of their disabling impact on cognition, memory, language, mobility, and adaptive skills. In addition to significant reduction in life expectancy each new malignant gliomas case impacts the nation's public health since its morbidity represents on average twenty years of lost productivity. Whether the payer is public or private, diagnosis and treatment, including supportive care in the terminal stages of disease, extracts enormous health care expenditures.

Filed on September 27, 2013.

Name	Institution	Type	Company	Disclosed Value
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Imanis Life Sciences	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad (fka Omnis Pharma and Magnis)	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad, Inc. (fka Omnis Pharma and Magnis Thera)	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Arizona	Conflict of Interest	Vyriad, Inc.	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Omnis Pharma	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad, Inc.	$0 - $4,999
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad, Inc.	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad, Inc.	Value cannot be readily determined
Kah Whye Peng	Mayo Clinic Rochester	Conflict of Interest	Vyriad, Inc.	Value cannot be readily determined

If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.

Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.